Gulgun Yalcinkaya, MD
-
Specialty: Neonatology
View Expertise -
Primary Location: 5850 Landerbrook Dr (7 mi.)
Other Locations - Languages Spoken: English, Turkish
Office Locations
DO 5850 Landerbrook (7 mi.)
5850 Landerbrook Dr
Ste 220
Mayfield Heights, OH 44124
440-646-8055
RBC Rainbow Babies & Childrens (0 mi.)
11100 Euclid Ave
Ste 170
Cleveland, OH 44106
216-844-7770
UH Regional Hospitals - Geauga Campus (21 mi.)
13207 Ravenna Rd
Chardon, OH 44024
440-285-6000
Biography: Gulgun Yalcinkaya, MD
Expertise
Titles
- Medical Director, NICU Step Down Unit, UH Rainbow Babies and Children's Hospital
- Assistant Professor, CWRU School of Medicine
Certifications & Memberships
- Neonatal/Perinatal Medicine - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
Education
Fellowship | Neonatal-Perinatal Medicine
Neonatal-Perinatal Medicine - New York University School Of Medicine And Langone Medical Center (1994 - 1997)
Residency | Pediatrics
Pediatrics - New York University School Of Medicine And Langone Medical Center (1992 - 1994)
Internship | Pediatrics
Pediatrics - New York University School Of Medicine And Langone Medical Center (1991 - 1992)
Medical Education
Istanbul Universitesi Cerrahpasa Tip Fakultesi (1989)
About
Gulgun Yalcinkaya, MD received her medical education at Istanbul Universitesi Cerrahpasa Tip Fakultesi in Turkey and went on to complete her pediatric residency and fellowship at New York University Medical Center. Dr. Yalcinkaya is involved with neonatal follow-up clinic and is co-director of the Transitional Care Nursery. Dr. Yalcinkaya is the Director of MS3 Neonatology Medical Education and also oversees the Neonatal Observership Program.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Gulgun Yalcinkaya did not disclose any Outside Relationships with Industry.